We will operate as a privately held company, fully compliant with energy sector regulations and assistive technology guidelines. Initial offerings will target predictive maintenance and grid diagnostics for renewable installations, with future expansion into low-cost medical exoskeletons.
Development Timeline
(2025–2028)
Phase I (2025):
Simulations, pilot sensor networks, and exoskeleton prototyping
Phase II (Late 2025):
MVPs for diagnostics and mobility support
Phase III (2026):
Formal incorporation, hiring, and academic collaboration
Phase IV (2027):
Product diversification and federal grant applications
Phase V (2028):
National scaling and export of the RenewPower toolkit
2028 Goals
Metric | Target |
---|---|
Clients Onboarded | 25+ across energy and health |
High-Skilled Jobs Created | 15–20 |
Federal Grants Raised | $600K+ |
Product Modules Released | 3+ (diagnostics, IoT, rehab) |
Academic Partnerships | 3+ institutions |
Failure Reduction in Systems | ≥30% in pilot sites |